This study by Tomaszewski M et al. found that patients with CHD-PAH, CTD-PAH, and CTEPH had higher IL-6, IFN-gamma, and IL-2 levels than the control group. Here, IL2 is linked to chronic thromboembolic pulmonary hypertension.